Css LLC Spdr Ser Tr Spdr S&P Biotech E Call Options Transaction History

Css LLC

$999 Million
Q3 2024

Call Options

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q1 2022 May 16, 2022	BUY	$81.07 - $115.44 $202,674 - $288,600	2,500 Added 16.67%	17,500 $1.57 Million
Q1 2021 May 17, 2021	BUY	$129.36 - $173.99 $646,800 - $869,950	5,000 Added 50.0%	15,000 $2.03 Million
Q4 2020 Feb 16, 2021	SELL	$110.36 - $151.14 $231,756 - $317,394	-2,100 Reduced 17.36%	10,000 $1.41 Million
Q2 2020 Aug 14, 2020	BUY	$73.26 - $114.17 $886,446 - $1.38 Million	12,100 New	12,100 $1.36 Million
Q1 2020 May 15, 2020	SELL	$65.95 - $98.35 $989,250 - $1.48 Million	-15,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$74.65 - $98.46 $1.12 Million - $1.48 Million	15,000 New	15,000 $1.43 Million

Others Institutions Holding XBI

# of Institutions

927

Shares Held

101M

Call Options Held

28.4M

Put Options Held

33.4M

Goldman Sachs Group Inc New York, NY

12.7M
Shares

$1.18 Billion
0.21% of portfolio
Jpmorgan Chase & CO New York, NY

12.3M
Shares

$1.14 Billion
0.1% of portfolio
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A6

9.23M
Shares

$855 Million
2.24% of portfolio
Morgan Stanley New York, NY

8.02M
Shares

$743 Million
0.06% of portfolio
Citigroup Inc

7.75M
Shares

$718 Million
0.45% of portfolio

About SPDR SER TR SPDR S&P BIOTECH E

Ticker XBI
Sector ETFs
Industry ETFs

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

News

Stay updated on Css LLC with notifications on news.